Literature DB >> 30755019

Effect of canagliflozin use on body weight and blood pressure at one-year follow-up: A systematic review and meta-analysis.

Muhammad Shahzeb Khan1, Muhammad Shariq Usman2, Tariq Jamal Siddiqi2, Muhammad Mustafa Memon2, Sanjiv J Shah3, Sadiya S Khan3.   

Abstract

Entities:  

Year:  2019        PMID： 30755019     DOI： 10.1177/2047487319829940

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN： 2047-4873            Impact factor:   7.804


× No keyword cloud information.
  5 in total

Review 1.  Diabetes: how to manage overweight and obesity in type 2 diabetes mellitus.

Authors:  Megan Wesling; Jennifer J D'Souza
Journal:  Drugs Context       Date:  2022-06-14

Review 2.  Effect of ertugliflozin on glycemic levels, blood pressure and body weight of patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  Maryam Zaman; Roha Saeed Memon; Arooba Amjad; Tehlil Rizwan; Jai Kumar; Ibtehaj Ul Haque; Syed Saad Ali; Lin Li; Muhammad Shariq Usman
Journal:  J Diabetes Metab Disord       Date:  2020-09-03

Review 3.  Sodium-Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes.

Authors:  Muhammad Shahzeb Khan; Javed Butler
Journal:  Card Fail Rev       Date:  2019-11-04

Review 4.  What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?

Authors:  Muhammad Shahzeb Khan; Muthiah Vaduganathan
Journal:  Curr Diab Rep       Date:  2020-10-11       Impact factor: 4.810

5.  Sodium Glucose Cotransporter Type 2 Inhibitors Improve Cardiorenal Outcome of Patients With Coronary Artery Disease: A Meta-Analysis.

Authors:  Wen Wei; Jin Liu; Shiqun Chen; Xinghao Xu; Dachuan Guo; Yibo He; Zhidong Huang; Bo Wang; Haozhang Huang; Qiang Li; Jiyan Chen; Hong Chen; Ning Tan; Yong Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-07       Impact factor: 5.555
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.